Frontiers in CNS Drug Discovery, vol 2

被引:0
|
作者
Ames, David [1 ]
机构
[1] Natl Ageing Res Inst, Parkville, Vic, Australia
关键词
D O I
10.1017/S1041610214000350
中图分类号
B849 [应用心理学];
学科分类号
040203 ;
摘要
引用
收藏
页码:873 / 873
页数:1
相关论文
共 50 条
  • [21] Positron Emission Tomography in CNS Drug Discovery and Drug Monitoring
    Piel, Markus
    Vernaleken, Ingo
    Roesch, Frank
    JOURNAL OF MEDICINAL CHEMISTRY, 2014, 57 (22) : 9232 - 9258
  • [22] Frontiers and Approaches in Anticancer Drug Discovery: An Editorial Overview
    Zaib, Sumera
    Khan, Imtiaz
    ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY, 2023, 23 (08) : 867 - 868
  • [23] Special Issue: Frontiers in Antimicrobial Drug Discovery and Design
    Barlocco, Daniela
    Meneghetti, Fiorella
    MOLECULES, 2017, 22 (07):
  • [24] Part II: new frontiers in antibacterial drug discovery
    Moloney, Mark G.
    FUTURE MEDICINAL CHEMISTRY, 2016, 8 (10) : 1015 - 1016
  • [25] New Frontiers in Drug Discovery: Academia Meets Industry at the International Helmholtz Drug Discovery Conference (HDDC)
    Goettlicher, Martin
    Sattler, Michael
    Broenstrup, Mark
    CHEMMEDCHEM, 2020, 15 (05) : 468 - 470
  • [26] Pharmacological MRI: a biomarker in CNS drug discovery and development?
    Lucignani, Giovanni
    Bastianello, Stefano
    FUNCTIONAL NEUROLOGY, 2007, 22 (02) : 71 - 73
  • [27] Drug Discovery for CNS Disorders: From Bench to Bedside
    Kazantsev, Aleksey G.
    Outeiro, Tiago Fleming
    CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS, 2010, 9 (06) : 668 - 668
  • [28] Neurotransmitter transporters: fruitful targets for CNS drug discovery
    Iversen, L
    MOLECULAR PSYCHIATRY, 2000, 5 (04) : 357 - 362
  • [29] Of Mice and MenBridging the Translational Disconnect in CNS Drug Discovery
    Hugo Geerts
    CNS Drugs, 2009, 23 : 915 - 926
  • [30] Modeling of PET data in CNS drug discovery and development
    Katarina Varnäs
    Andrea Varrone
    Lars Farde
    Journal of Pharmacokinetics and Pharmacodynamics, 2013, 40 : 267 - 279